Search Results 1111-1120 of 17138 for Birth Control Evolution

  1. Differences in Blood Cell Types in Peripheral Arterial Disease and Healthy Subjects - Mayo Clinic

    Poorly controlled diabetes (HbA1c > 8%). BMI < 18 or > 35. Recent other major surgery or illness within 30 days. Use of immunosuppresive medications or ...

  2. A Study to Evaluate Patient Reported Outcome Measures in Children with Eye Conditions - Mayo Clinic

    The objectives of this study are: To evaluate patient-reported quality of life and functional vision across the spectrum of pediatric eye conditions;; To assess ...

  3. A Study to Evaluate the Effectiveness and Safety of MEDI2070 in Subjects with Active Moderate to Severe Crohn's Disease - Mayo Clinic

    Effective contraception from screening and for 36 weeks after the last dose of investigational product, including for female partners of male study subjects ...

  4. Ceftolozane/Tazobactam in Pediatric Patients With Nosocomial Pneumonia - Mayo Clinic

    ... birth (at least seven days postnatal) to less than 18 years of age with a diagnosis of confirmed or suspected nosocomial pneumonia (NP), including hospital ...

  5. A Study to Develop the Use of Ultrasound to Monitor Treatment of Crohn's Disease - Mayo Clinic

    ... management of Crohn's disease. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date ...

  6. A Study of Performing the King-Devick Concussion Test in a Right and Left Neck Rotation - Mayo Clinic

    Control group. No history of concussion. Concussion group (no symptoms). Three days to 3 weeks post-concussion; Determination of sustained concussion based on ...

  7. Evaluatiion of In-Home Urgent Care Services by Pairing In-Person and Virtual Clinicians in a Rural Community - Mayo Clinic

    About this study. The purpose of this study is to collect data about patient diagnosis, treatment, outcomes, prognosis, satisfaction, safety, quality, ...

  8. Research: It's all about patients - Mayo Clinic

    Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is to ...

  9. A Study to Assess the Effectiveness and Safety of Ublituximab in combination with Umbralisib and Venetoclax (U2-V) Compared to Ublituximab and Umbralisib (U2) in Subjects with Chronic Lymphocytic Leukemia (CLL) - Mayo Clinic

    Patients requiring systemic steroids for leukemia control or white blood cell (WBC)-count lowering are excluded. Autologous hematologic stem cell transplant ...

  10. Assessing the Patient Experience in Cancer Care - Mayo Clinic

    ... control, complementary/alternative therapies, costs, treatment burden, prognosis, anxiety, side-effects, sexual function, palliative care options, etc.) ...